v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income/(Loss)
Beginning Balance at Dec. 31, 2024 $ 835,619 $ 7 $ 1,591,707 $ (754,610) $ (1,485)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024   64,890,193      
Exercise of stock options 535   535    
Exercise of stock options, Shares   75,652      
Vesting restricted stock, Shares   146,869      
Stock-based compensation expense 14,233   14,233    
Unrealized loss on marketable securities 1,427       1,427
Net loss (65,581)     (65,581)  
Ending Balance at Mar. 31, 2025 786,233 $ 7 1,606,475 (820,191) (58)
Shares, Outstanding, Ending Balance at Mar. 31, 2025   65,112,714      
Beginning Balance at Dec. 31, 2025 1,579,664 $ 8 2,643,817 (1,065,961) (1,800)
Shares, Outstanding, Beginning Balance at Dec. 31, 2025   81,323,532      
Exercise of stock options 19,194   19,194    
Exercise of stock options, Shares   669,517      
Vesting restricted stock, Shares   189,052      
Stock-based compensation expense 16,007   16,007    
Unrealized loss on marketable securities 5,994       (5,994)
Net loss (69,234)     (69,234)  
Ending Balance at Mar. 31, 2026 $ 1,539,637 $ 8 $ 2,679,018 $ (1,135,195) $ (4,194)
Shares, Outstanding, Ending Balance at Mar. 31, 2026   82,182,101